PRESS RELEASE published on 01/17/2024 at 12:00, 2 years 8 months ago UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
Published on 09/28/2026 at 15:00, 3 hours 13 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 3 hours 28 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 3 hours 43 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 14:30, 3 hours 43 minutes ago Predictiv AI Completes United Nations Fleet Management Deployment Following Competitive Procurement Win
Published on 09/28/2026 at 14:00, 4 hours 13 minutes ago DoJ and DoW move to Support Resumption of Operations at Colosseum
Published on 09/28/2026 at 18:00, 13 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 13 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:53, 20 minutes ago EQS-Adhoc: MeVis Medical Solutions AG: Forecast Adjustment for Fiscal Year 2025/2026
Published on 09/28/2026 at 17:49, 23 minutes ago XTPL increased its global project pipeline in H1 2026, building more sales opportunities for subsequent periods
Published on 09/28/2026 at 17:45, 27 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 21-25 September 2026
Published on 09/28/2026 at 17:54, 18 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 18 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:35, 38 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026